Short versus long trans-pulmonary needle pathway for CT-guided percutaneous core needle biopsy of small sub-pleural pulmonary nodules
DOI:
https://doi.org/10.3126/jgmc-n.v19i1.86680Keywords:
CT-guided biopsy, pneumothorax, pulmonary nodule, sub-pleural.Abstract
Introduction: Short lesion-pleural distance allows little space for manipulation of biopsy needle with high risk of needle dislodgement into pleural space causing air leak and subsequently pneumothorax. This study compared short trans-pulmonary biopsy approach with long trans-pulmonary approach for small sub-pleural pulmonary nodule to determine approach with lesser complication and better diagnostic yield.
Methods: A total of 65 patients who were undergoing CT guided biopsy for small (≤20 mm) sub-pleural (≤10 mm) pulmonary nodules were divided into two groups depending upon biopsy approach, i.e., long trans-pulmonary biopsy approach (group A, n=34) and short trans-pulmonary biopsy approach (group B, n=31). Diagnostic accuracy and complication rate between the groups were compared.
Results: No significant difference was found between two groups in case of diagnostic accuracy (Group A vs Group B: 91.2% vs 87.1%; p=0.59). Pneumothorax rate was higher in group B (29.0%) compared to group A (14.7%), however, difference was not statistically significant (p=0.16). Among risk factors for pneumothorax, smaller lesion size (5-10 mm), short lesion-pleural distance (≤ 5 mm) and number of pleural passes (>1) was associated with significantly higher pneumothorax rate in group B compared to group A (71.4 vs 40% p=0.02; 85.7% vs 16.6% p=0.01; 100% vs 57.1% p=0.01 respectively).
Conclusions: Smaller sub-pleural pulmonary nodules render high risk of pneumothorax with the use of short trans-pulmonary pathway. If the nodule is very close to pleura and relatively smaller where one could not ensure access with single puncture, long trans-pulmonary pathway serves as safer option to avoid pneumothorax.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.